133 related articles for article (PubMed ID: 11294751)
1. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats.
Jia DM; Fukumitsu KI; Tabaru A; Akiyama T; Otsuki M
Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1332-40. PubMed ID: 11294751
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone stimulates pancreatic growth in normal rats.
Jia DM; Otsuki M
Pancreas; 2002 Apr; 24(3):303-12. PubMed ID: 11893940
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.
Furuta M; Yano Y; Gabazza EC; Araki-Sasaki R; Tanaka T; Katsuki A; Hori Y; Nakatani K; Sumida Y; Adachi Y
Diabetes Res Clin Pract; 2002 Jun; 56(3):159-71. PubMed ID: 11947963
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats.
Kosegawa I; Chen S; Awata T; Negishi K; Katayama S
Clin Exp Hypertens; 1999 Apr; 21(3):199-211. PubMed ID: 10225476
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes.
Jia DM; Tabaru A; Nakamura H; Fukumitsu KI; Akiyama T; Otsuki M
Metabolism; 2000 Sep; 49(9):1167-75. PubMed ID: 11016899
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone ameliorates abnormal activity of protein tyrosine phosphatase in adipose tissues of Otsuka Long-Evans Tokushima Fatty rats.
Tagami S; Honda T; Yoshimura H; Homma H; Ohno K; Ide H; Sakaue S; Kawakami Y
Tohoku J Exp Med; 2002 Jul; 197(3):169-81. PubMed ID: 12365558
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone prevents fatty changes of the liver in obese diabetic rats.
Jia DM; Tabaru A; Akiyama T; Abe S; Otsuki M
J Gastroenterol Hepatol; 2000 Oct; 15(10):1183-91. PubMed ID: 11106100
[TBL] [Abstract][Full Text] [Related]
8. Effect of troglitazone on exocrine pancreas in rats with streptozotocin-induced diabetes mellitus.
Shimizu K; Shiratori K; Hayashi N; Fujiwara T; Horikoshi H
Pancreas; 2000 Nov; 21(4):421-6. PubMed ID: 11075998
[TBL] [Abstract][Full Text] [Related]
9. Role of cholecystokinin (CCK)-A receptor for pancreatic growth after weaning: a study in a new rat model without gene expression of the CCK-A receptor.
Miyasaka K; Ohta M; Kanai S; Sato Y; Masuda M; Funakoshi A
Pancreas; 1996 May; 12(4):351-6. PubMed ID: 8740401
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone improves blood flow by inhibiting neointimal formation after balloon injury in Otsuka Long-Evans Tokushima fatty rats.
Min KM; Park SW; Cho KY; Song MS; Kim DK; Park GS; Lee MK
Metabolism; 2002 Aug; 51(8):998-1002. PubMed ID: 12145772
[TBL] [Abstract][Full Text] [Related]
11. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
Jia D; Taguchi M; Otsuki M
Pancreas; 2005 Jan; 30(1):54-61. PubMed ID: 15632700
[TBL] [Abstract][Full Text] [Related]
12. Dietary troglitazone decreases oxidative stress in early stage type II diabetic rats.
Fukui T; Noma T; Mizushige K; Aki Y; Kimura S; Abe Y
Life Sci; 2000 Apr; 66(21):2043-9. PubMed ID: 10823344
[TBL] [Abstract][Full Text] [Related]
13. Treatment for hyperglycemia promotes pancreatic regeneration in rats without CCK-1 receptor gene expression.
Yamamoto M; Jia DM; Fukumitsu K; Otsuki M
Pancreas; 2003 May; 26(4):368-74. PubMed ID: 12717270
[TBL] [Abstract][Full Text] [Related]
14. Thiazolidinedione derivatives as novel therapeutic agents to prevent the development of chronic pancreatitis.
Shimizu K; Shiratori K; Hayashi N; Kobayashi M; Fujiwara T; Horikoshi H
Pancreas; 2002 Mar; 24(2):184-90. PubMed ID: 11854624
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone improves endothelial function and augments renal klotho mRNA expression in Otsuka Long-Evans Tokushima Fatty (OLETF) rats with multiple atherogenic risk factors.
Yamagishi T; Saito Y; Nakamura T; Takeda S; Kanai H; Sumino H; Kuro-o M; Nabeshima Y; Kurabayashi M; Nagai R
Hypertens Res; 2001 Nov; 24(6):705-9. PubMed ID: 11768731
[TBL] [Abstract][Full Text] [Related]
16. Effect of obesity and troglitazone on expression of two glutathione peroxidases: cellular and extracellular types in serum, kidney and adipose tissue.
Asayama K; Nakane T; Dobashi K; Kodera K; Hayashibe H; Uchida N; Nakazawa S
Free Radic Res; 2001 Apr; 34(4):337-47. PubMed ID: 11328671
[TBL] [Abstract][Full Text] [Related]
17. Effects of troglitazone on collagen accumulation and distensibility of aortic wall in prestage of non-insulin-dependent diabetes mellitus of Otsuka Long-Evans Tokushima Fatty rats.
Mizushige K; Noma T; Yao L; Yu Y; Kiyomoto H; Hosomi N; Fukui T; Kimura S; Abe Y; Matsuo H
J Cardiovasc Pharmacol; 2000 Jan; 35(1):150-5. PubMed ID: 10630746
[TBL] [Abstract][Full Text] [Related]
18. Increased gastric acid secretion in cholecystokinin-1 receptor-deficient Otsuka Long-Evans Tokushima fatty rats.
Kanagawa K; Nakamura H; Murata I; Yosikawa I; Otsuki M
Scand J Gastroenterol; 2002 Jan; 37(1):9-16. PubMed ID: 11843043
[TBL] [Abstract][Full Text] [Related]
19. Effect of timely insulin administration on pancreatic B-cells of Otsuka-Long-Evans-Tokushima-Fatty (OLETF) strain rats. An animal model of non-insulin dependent diabetes mellitus (NIDDM).
Ishida K; Mizuno A; Sano T; Noma Y; Shima K
Horm Metab Res; 1995 Sep; 27(9):398-402. PubMed ID: 8557237
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
